Poised For A 29.89% Upside
Prestige Consumer Healthcare Inc. (NYSE: PBH), a notable player in the healthcare sector, is capturing investor attention with its diverse portfolio of over-the-counter (OTC) health and personal care products. Headquartered in Tarrytown, New York, Prestige operates across North America, Australia, and beyond, offering well-known brands such as Chloraseptic, Clear Eyes, Compound W, and Dramamine. Despite recent challenges, the company’s robust market presence and strategic brand portfolio suggest potential for significant stock appreciation.
Currently trading at $62.23, Prestige Consumer Healthcare’s stock has experienced a slight decline of 0.36% recently. However, analysts are optimistic, as demonstrated by a consensus target…
